Mgenplus Co. Ltd. Total Assets

Latest as of June 2026: ₩49.99 Billion KRW ≈ $33.88 Million USD

Mgenplus Co. Ltd. total assets. Based on the latest financial reports, Mgenplus Co. Ltd. (032790) holds total assets worth ₩49.99 Billion KRW (≈ $33.88 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Mgenplus Co. Ltd. market cap and net worth for the company's overall valuation and market capitalisation.

Total Assets of Mgenplus Co. Ltd. (2006–2025)

Total assets of Mgenplus Co. Ltd. from 2006 to 2025. This chart illustrates how Mgenplus Co. Ltd.'s total assets have evolved over time, based on quarterly financial data. See 032790 live share price for real-time trading data and today's change.

Mgenplus Co. Ltd. - Asset Composition Analysis

Mgenplus Co. Ltd. Total Assets Breakdown (December 2025)

Mgenplus Co. Ltd. total assets breakdown as of December 2025. Mgenplus Co. Ltd.'s total assets of ₩49.99 Billion consist of 51.1% current assets and 49.0% non-current assets.

Asset Category Amount (KRW) % of Total Assets
Cash & Equivalents ₩0.00 21.8%
Accounts Receivable ₩5.19 Billion 8.7%
Inventory ₩3.73 Billion 6.2%
Property, Plant & Equipment ₩0.00 0.0%
Intangible Assets ₩3.35 Billion 5.6%
Goodwill ₩1.17 Billion 2.0%

Asset Composition Trend (2006–2025)

This chart illustrates how Mgenplus Co. Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore 032790 net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Mgenplus Co. Ltd.'s current assets represent 51.1% of total assets in 2025, an increase from 0.0% in 2006.
  • Cash Position: Cash and equivalents constituted 21.8% of total assets in 2025, up from 2.7% in 2006.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 4.0% in 2006.
  • Asset Diversification: The largest asset category is accounts receivable at 8.7% of total assets.

Mgenplus Co. Ltd. Competitors by Total Assets

Key competitors of Mgenplus Co. Ltd. based on total assets are shown below.

Company Country Total Assets
argenx NV ADR
NASDAQ:ARGX
USA $10.03 Billion
Pharmaron Beijing Co Ltd
SHE:300759
China CN¥25.80 Billion
PHARVARIS N.V. EO -12
F:9EN
Germany €301.45 Million
GH RESEARCH PLC DL-025
F:1KA
Germany €372.35 Million
MoonLake Immunotherapeutics
NASDAQ:MLTX
USA $400.37 Million
Savara Inc
NASDAQ:SVRA
USA $192.14 Million
INVENTIVA ADS/1 O.N.
F:6IVA
Germany €249.51 Million
Innovita Biological Technology Co. Ltd. A
SHG:688253
China CN¥2.23 Billion

Mgenplus Co. Ltd. - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.07 1.45 1.88
Quick Ratio 0.89 1.30 1.60
Cash Ratio 0.00 0.00 0.00
Working Capital ₩1.50 Billion ₩10.16 Billion ₩10.79 Billion

Mgenplus Co. Ltd. - Advanced Valuation Insights

This section examines the relationship between Mgenplus Co. Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.51
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) -16.2%
Total Assets ₩59.85 Billion
Market Capitalization $20.36 Million USD

Valuation Analysis

Below Book Valuation: The market values Mgenplus Co. Ltd.'s assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Mgenplus Co. Ltd.'s assets decreased by 16.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Mgenplus Co. Ltd. (2006–2025)

The table below shows the annual total assets of Mgenplus Co. Ltd. from 2006 to 2025.

Year Total Assets Change
2025-12-31 ₩59.85 Billion
≈ $40.56 Million
-16.21%
2024-12-31 ₩71.42 Billion
≈ $48.40 Million
+6.14%
2023-12-31 ₩67.29 Billion
≈ $45.60 Million
-11.41%
2022-12-31 ₩75.96 Billion
≈ $51.48 Million
+45.85%
2018-12-31 ₩52.08 Billion
≈ $35.29 Million
+44.70%
2017-12-31 ₩35.99 Billion
≈ $24.39 Million
+22.28%
2016-12-31 ₩29.43 Billion
≈ $19.95 Million
+7.97%
2015-12-31 ₩27.26 Billion
≈ $18.47 Million
-15.19%
2014-12-31 ₩32.14 Billion
≈ $21.78 Million
-21.78%
2013-12-31 ₩41.10 Billion
≈ $27.85 Million
-17.40%
2012-12-31 ₩49.76 Billion
≈ $33.72 Million
+5.03%
2011-12-31 ₩47.37 Billion
≈ $32.11 Million
+4.95%
2008-12-31 ₩45.14 Billion
≈ $30.59 Million
+5.61%
2007-12-31 ₩42.74 Billion
≈ $28.97 Million
-3.82%
2006-12-31 ₩44.44 Billion
≈ $30.12 Million
--

About Mgenplus Co. Ltd.

KQ:032790 Korea Biotechnology
Market Cap
$20.36 Million
₩30.05 Billion KRW
Market Cap Rank
#24904 Global
#1813 in Korea
Share Price
₩1170.00
Change (1 day)
-3.54%
52-Week Range
₩800.00 - ₩1631.00
All Time High
₩1631.00
About

Mgen Solutions Co., Ltd. engages in broadband communication network construction business. The company offers electricity, bio business and fire facility construction business, firefighting equipment and construction; printer developer; manufacturing and supply of electrical and electronic products such as transformers and inductors; artificial intelligence video analysis solution; printer develo… Read more